STOCK TITAN

[Form 4] GeneDx Holdings Corp. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Keith A. Meister, Director and 10% Owner of GeneDx Holdings, reported multiple transactions in company securities on June 18, 2025:

  • Acquired 12,924 shares of Class A Common Stock through the conversion of Restricted Stock Units (RSUs) at $0 cost
  • Received a new grant of 3,576 RSUs that will vest at the earlier of next annual shareholder meeting or first grant anniversary
  • Following transactions, directly owns 20,129 shares and indirectly controls 3,674,913 shares

Indirect ownership includes 333,144 shares through CMLS Holdings LLC, where Meister serves on Board of Managers, and 3,341,769 shares through Corvex Management LP, where he controls the general partner. The transactions demonstrate continued insider investment aligned with long-term shareholder interests.

Keith A. Meister, Direttore e proprietario del 10% di GeneDx Holdings, ha comunicato diverse operazioni su titoli della società il 18 giugno 2025:

  • Ha acquisito 12.924 azioni di Azioni Ordinarie Classe A tramite la conversione di Restricted Stock Units (RSU) a costo zero
  • Ha ricevuto una nuova assegnazione di 3.576 RSU che matureranno al momento della prossima assemblea annuale degli azionisti o al primo anniversario della concessione, a seconda di quale evento si verifichi prima
  • Dopo queste operazioni, detiene direttamente 20.129 azioni e controlla indirettamente 3.674.913 azioni

La proprietà indiretta comprende 333.144 azioni tramite CMLS Holdings LLC, dove Meister fa parte del Consiglio di Amministrazione, e 3.341.769 azioni tramite Corvex Management LP, dove controlla il socio accomandatario. Queste operazioni riflettono un continuo investimento interno in linea con gli interessi azionari a lungo termine.

Keith A. Meister, Director y propietario del 10% de GeneDx Holdings, reportó múltiples transacciones con valores de la compañía el 18 de junio de 2025:

  • Adquirió 12,924 acciones de Acciones Comunes Clase A mediante la conversión de Unidades de Acciones Restringidas (RSU) sin costo
  • Recibió una nueva asignación de 3,576 RSU que se consolidarán en la fecha que ocurra primero: la próxima junta anual de accionistas o el primer aniversario de la concesión
  • Tras estas transacciones, posee directamente 20,129 acciones y controla indirectamente 3,674,913 acciones

La propiedad indirecta incluye 333,144 acciones a través de CMLS Holdings LLC, donde Meister forma parte del Consejo de Administración, y 3,341,769 acciones a través de Corvex Management LP, donde controla al socio general. Estas transacciones evidencian una inversión interna continua alineada con los intereses a largo plazo de los accionistas.

Keith A. Meister, GeneDx Holdings의 이사이자 10% 지분 보유자는 2025년 6월 18일 회사 증권에 관한 여러 거래를 보고했습니다:

  • 무상으로 제한 주식 단위(RSU)를 전환하여 클래스 A 보통주 12,924주를 취득함
  • 다음 연례 주주총회 또는 최초 부여 기념일 중 빠른 시점에 권리가 확정되는 3,576 RSU를 새로 부여받음
  • 이 거래 이후 직접 보유 주식은 20,129주이고 간접적으로는 3,674,913주를 통제함

간접 소유는 Meister가 이사회 멤버로 활동 중인 CMLS Holdings LLC를 통해 333,144주, 그리고 그가 일반 파트너를 통제하는 Corvex Management LP를 통해 3,341,769주를 포함합니다. 이 거래들은 장기 주주 이익에 부합하는 내부자의 지속적인 투자임을 보여줍니다.

Keith A. Meister, Directeur et détenteur de 10% des parts de GeneDx Holdings, a déclaré plusieurs transactions sur les titres de la société le 18 juin 2025 :

  • A acquis 12 924 actions ordinaires de classe A via la conversion d'Unités d'Actions Restreintes (RSU) sans coût
  • A reçu une nouvelle attribution de 3 576 RSU qui seront acquises à la date la plus proche entre la prochaine assemblée annuelle des actionnaires ou le premier anniversaire de la remise
  • Après ces transactions, il détient directement 20 129 actions et contrôle indirectement 3 674 913 actions

La propriété indirecte comprend 333 144 actions via CMLS Holdings LLC, où Meister siège au conseil d'administration, et 3 341 769 actions via Corvex Management LP, où il contrôle le commandité. Ces transactions témoignent d'un investissement interne continu, aligné avec les intérêts à long terme des actionnaires.

Keith A. Meister, Direktor und 10% Eigentümer von GeneDx Holdings, meldete am 18. Juni 2025 mehrere Transaktionen mit Unternehmenswertpapieren:

  • Erwarb 12.924 Aktien der Klasse A Stammaktien durch die Umwandlung von Restricted Stock Units (RSUs) ohne Kosten
  • Erhielt eine neue Zuteilung von 3.576 RSUs, die entweder bei der nächsten jährlichen Hauptversammlung oder am ersten Jahrestag der Zuteilung fällig werden, je nachdem, was zuerst eintritt
  • Nach diesen Transaktionen besitzt er direkt 20.129 Aktien und kontrolliert indirekt 3.674.913 Aktien

Der indirekte Besitz umfasst 333.144 Aktien über CMLS Holdings LLC, in deren Verwaltungsrat Meister sitzt, sowie 3.341.769 Aktien über Corvex Management LP, wo er den Generalpartner kontrolliert. Diese Transaktionen zeigen eine fortgesetzte Insider-Investition, die mit den langfristigen Interessen der Aktionäre übereinstimmt.

Positive
  • None.
Negative
  • None.

Keith A. Meister, Direttore e proprietario del 10% di GeneDx Holdings, ha comunicato diverse operazioni su titoli della società il 18 giugno 2025:

  • Ha acquisito 12.924 azioni di Azioni Ordinarie Classe A tramite la conversione di Restricted Stock Units (RSU) a costo zero
  • Ha ricevuto una nuova assegnazione di 3.576 RSU che matureranno al momento della prossima assemblea annuale degli azionisti o al primo anniversario della concessione, a seconda di quale evento si verifichi prima
  • Dopo queste operazioni, detiene direttamente 20.129 azioni e controlla indirettamente 3.674.913 azioni

La proprietà indiretta comprende 333.144 azioni tramite CMLS Holdings LLC, dove Meister fa parte del Consiglio di Amministrazione, e 3.341.769 azioni tramite Corvex Management LP, dove controlla il socio accomandatario. Queste operazioni riflettono un continuo investimento interno in linea con gli interessi azionari a lungo termine.

Keith A. Meister, Director y propietario del 10% de GeneDx Holdings, reportó múltiples transacciones con valores de la compañía el 18 de junio de 2025:

  • Adquirió 12,924 acciones de Acciones Comunes Clase A mediante la conversión de Unidades de Acciones Restringidas (RSU) sin costo
  • Recibió una nueva asignación de 3,576 RSU que se consolidarán en la fecha que ocurra primero: la próxima junta anual de accionistas o el primer aniversario de la concesión
  • Tras estas transacciones, posee directamente 20,129 acciones y controla indirectamente 3,674,913 acciones

La propiedad indirecta incluye 333,144 acciones a través de CMLS Holdings LLC, donde Meister forma parte del Consejo de Administración, y 3,341,769 acciones a través de Corvex Management LP, donde controla al socio general. Estas transacciones evidencian una inversión interna continua alineada con los intereses a largo plazo de los accionistas.

Keith A. Meister, GeneDx Holdings의 이사이자 10% 지분 보유자는 2025년 6월 18일 회사 증권에 관한 여러 거래를 보고했습니다:

  • 무상으로 제한 주식 단위(RSU)를 전환하여 클래스 A 보통주 12,924주를 취득함
  • 다음 연례 주주총회 또는 최초 부여 기념일 중 빠른 시점에 권리가 확정되는 3,576 RSU를 새로 부여받음
  • 이 거래 이후 직접 보유 주식은 20,129주이고 간접적으로는 3,674,913주를 통제함

간접 소유는 Meister가 이사회 멤버로 활동 중인 CMLS Holdings LLC를 통해 333,144주, 그리고 그가 일반 파트너를 통제하는 Corvex Management LP를 통해 3,341,769주를 포함합니다. 이 거래들은 장기 주주 이익에 부합하는 내부자의 지속적인 투자임을 보여줍니다.

Keith A. Meister, Directeur et détenteur de 10% des parts de GeneDx Holdings, a déclaré plusieurs transactions sur les titres de la société le 18 juin 2025 :

  • A acquis 12 924 actions ordinaires de classe A via la conversion d'Unités d'Actions Restreintes (RSU) sans coût
  • A reçu une nouvelle attribution de 3 576 RSU qui seront acquises à la date la plus proche entre la prochaine assemblée annuelle des actionnaires ou le premier anniversaire de la remise
  • Après ces transactions, il détient directement 20 129 actions et contrôle indirectement 3 674 913 actions

La propriété indirecte comprend 333 144 actions via CMLS Holdings LLC, où Meister siège au conseil d'administration, et 3 341 769 actions via Corvex Management LP, où il contrôle le commandité. Ces transactions témoignent d'un investissement interne continu, aligné avec les intérêts à long terme des actionnaires.

Keith A. Meister, Direktor und 10% Eigentümer von GeneDx Holdings, meldete am 18. Juni 2025 mehrere Transaktionen mit Unternehmenswertpapieren:

  • Erwarb 12.924 Aktien der Klasse A Stammaktien durch die Umwandlung von Restricted Stock Units (RSUs) ohne Kosten
  • Erhielt eine neue Zuteilung von 3.576 RSUs, die entweder bei der nächsten jährlichen Hauptversammlung oder am ersten Jahrestag der Zuteilung fällig werden, je nachdem, was zuerst eintritt
  • Nach diesen Transaktionen besitzt er direkt 20.129 Aktien und kontrolliert indirekt 3.674.913 Aktien

Der indirekte Besitz umfasst 333.144 Aktien über CMLS Holdings LLC, in deren Verwaltungsrat Meister sitzt, sowie 3.341.769 Aktien über Corvex Management LP, wo er den Generalpartner kontrolliert. Diese Transaktionen zeigen eine fortgesetzte Insider-Investition, die mit den langfristigen Interessen der Aktionäre übereinstimmt.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Meister Keith A.

(Last) (First) (Middle)
C/O CORVEX MANAGEMENT LP
667 MADISON AVENUE

(Street)
NEW YORK NY 10065

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
GeneDx Holdings Corp. [ WGS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/18/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 06/18/2025 M 12,924 A $0(1) 20,129 D
Class A Common Stock 3,674,913 I See Footnotes(2)(3)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Unit (1) 06/18/2025 A 3,576 (4) (4) Class A Common Stock 3,576 $0 3,576 D
Restricted Stock Unit (1) 06/18/2025 M 12,924 (4) (4) Class A Common Stock 12,924 $0 0 D
Explanation of Responses:
1. Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
2. CMLS Holdings LLC ("CMLS Holdings") is the record holder of 333,144 shares of the Class A Common Stock reported herein. Mr. Meister is one of two members of the Board of Managers of CMLS Holdings, and Mr. Meister shares voting and investment discretion with respect to the securities held by CMLS Holdings Stock reported herein. Corvex is not an investment adviser to CMLS Holdings.
3. 3,341,769 shares of Class A Common Stock of the Issuer are held for the accounts of the Corvex Funds for which Corvex Management LP ("Corvex") acts as investment adviser. The general partner of Corvex is controlled by Mr. Meister.
4. The RSUs shall vest the earlier of (a) the date of the next annual meeting of the Issuer's shareholders following the grant date, and (b) the first anniversary of the grant date, subject to the Reporting Person continuing to provide services to the Issuer through each vesting date.
/s/ Bridget Brown, Attorney-in-Fact 06/23/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many shares of WGS stock did Keith Meister acquire on June 18, 2025?

On June 18, 2025, Keith Meister acquired 12,924 shares of WGS Class A Common Stock through the settlement of Restricted Stock Units (RSUs). Additionally, he was granted 3,576 new RSUs on the same date.

What is Keith Meister's total beneficial ownership position in WGS stock?

Following the reported transactions, Keith Meister beneficially owns 20,129 shares directly and 3,674,913 shares indirectly. The indirect ownership consists of 333,144 shares through CMLS Holdings LLC and 3,341,769 shares through Corvex Management LP's funds.

What positions does Keith Meister hold at WGS?

According to the Form 4 filing, Keith Meister serves as both a Director and a 10% Owner of GeneDx Holdings Corp (WGS).

What are the vesting terms for WGS's RSUs granted to Keith Meister?

The RSUs vest at the earlier of (a) the date of the next annual meeting of WGS's shareholders following the grant date, or (b) the first anniversary of the grant date, subject to the Reporting Person continuing to provide services to the company through each vesting date.

What is the exercise price of WGS RSUs granted to Keith Meister?

The RSUs have no exercise price. Each RSU represents a contingent right to receive 1 share of WGS Class A Common Stock upon settlement for no consideration.
GeneDx Holdings Corp

NASDAQ:WGS

WGS Rankings

WGS Latest News

WGS Latest SEC Filings

WGS Stock Data

3.37B
25.17M
12.35%
110.61%
12.65%
Diagnostics & Research
Services-health Services
Link
United States
STAMFORD